巴西、哥伦比亚和秘鲁监狱结核病系统筛查策略的比较影响与成本效果:数学建模研究
该研究利用校准至巴西、哥伦比亚和秘鲁的动态传播模型,模拟2026至2035年监狱系统筛查策略。结果显示,结合入狱、出狱筛查与每年两次的CXR-CAD筛查最具影响力和成本效果,可使监狱内结核病发病率降低61%-87%,人群层面降低18%-28%。
要点
- 入狱、出狱联合每年两次CXR-CAD筛查可大幅降低监狱及人群结核发病率。
- 在CXR-CAD不可及的场景, pooled Xpert是具影响力和成本效果的替代方案。
- 仅每年两次筛查在监狱发病率远低于全国平均水平时仍具成本效果。
核心结论
- 建模结果支持国家层面立即采用每年两次及入狱/出狱时监狱结核病筛查,使用CXR-CAD或pooled Xpert。
研究设计与样本
- 使用校准至巴西、哥伦比亚和秘鲁的动态传播模型,模拟2026至2035年监狱筛查策略。
- 评估每年一次或每年两次监狱全面筛查,单独或联合入狱和出狱筛查,并比较四种筛查算法。
主要发现
- 入狱、出狱联合每年两次CXR-CAD筛查使监狱结核发病率降低61%-87%,人群层面降低18%-28%。
- 相比仅每年两次CXR-CAD筛查,增加入狱和出狱筛查的每避免DALY增量成本为巴西2984美元、哥伦比亚2925美元、秘鲁645美元。
- 在CXR-CAD基础上增加症状筛查仅边际增加获益,仅在秘鲁高发病率监狱具成本效果。
- 在无CXR-CAD场景,pooled Xpert是具影响力和成本效果的替代方案。
临床怎么用
- 在巴西、哥伦比亚和秘鲁,可优先考虑入狱、出狱联合每年两次CXR-CAD筛查策略。
- 若CXR-CAD不可及,可选用pooled Xpert作为替代筛查算法。
局限性
- 模型简化了结核病疾病状态,未按年龄、性别、HIV或耐药进行分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incarceration is a leading driver of tuberculosis in Latin America. Systematic screening in prisons may reduce tuberculosis burden, but optimal strategies and cost-effectiveness remain uncertain. We examined the population-wide health impacts and cost-effectiveness of systematic screening in prisons in Brazil, Colombia, and Peru, comparing different timepoints, frequencies, and screening algorithms. METHODS AND FINDINGS: Using dynamic transmission models calibrated to Brazil, Colombia, and Peru, we simulated annual or biannual (twice-yearly) prison-wide screening, alone or combined with entry and exit screening from 2026 to 2035. We evaluated four algorithms: (1) symptom screening, (2) chest X-ray with computer-aided detection (CXR-CAD), (3) symptoms and CXR-CAD (follow-up testing if either is positive), and (4) GeneXpert Ultra (Xpert) with pooled sputum. Individuals screening positive then received individual Xpert. We projected impacts on within-prison and population-level tuberculosis incidence in 2035, along with discounted costs (2023 US dollars) and disability-adjusted life years (DALYs). Model projections showed that combined entry, exit, and biannual screening with CXR-CAD was highly impactful and cost-effective across countries, reducing tuberculosis incidence by 61%-87% in prisons and 18%-28% population-wide. Compared to only biannual CXR-CAD (the next best strategy), the incremental cost per DALY averted of adding entry and exit screening was $2,984 (Brazil), $2,925 (Colombia), and $645 (Peru). Adding symptom screening to CXR-CAD marginally increased benefit and was only cost-effective in Peru's higher-incidence prisons. Biannual screening alone remained cost-effective at prison incidence levels well below national averages, as well as at far lower willingness-to-pay thresholds. In settings without CXR-CAD, pooled Xpert was an impactful, cost-effective alternative. Key limitations include the model's simplified representation of tuberculosis disease states and lack of stratification by age, gender/sex, HIV, or drug resistance. CONCLUSIONS: These modeling results support immediate national-level adoption of prison-wide tuberculosis screening twice-yearly and at entry and exit, using CXR-CAD or pooled Xpert.
引用
- Liu YE, Bampi JVB, Arthur RF, et al. Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study. PLoS Med. 2026. PMID: 42241460. doi:10.1371/journal.pmed.1004739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。